GBS, also known as classic or ascending paralysis, begins in the lower limbs and is technically called Acute Inflammatory ...

MUMBAI: The tally of Guillain Barre Syndrome (GBS) cases in Maharashtra has reached 189, while the first GBS-suspected patient from Andheri-East was detect ...

Guggenheim Securities adjusted its price target for Immunovant shares, listed on (NASDAQ:IMVT), to $44.00, a decrease from the previous $46.00, while sustaining a Buy rating on the stock. Currently ...

H.C. Wainwright reaffirmed their Buy rating on Immunovant (NASDAQ:IMVT) shares with a price target of $51.00, aligning with the broader Wall Street sentiment. According to InvestingPro data, analyst ...

"The suicides are a result of not knowing there is support, not being able to reach out for help to access the support that ...

SE (NASDAQ:ARGX – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst ...

Choreo LLC lifted its holdings in argenx SE (NASDAQ:ARGX – Free Report) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

The tally of suspected Guillain-Barré syndrome (GBS) cases in the Pune region has reached 180, with the detection of seven ...

Mumbai reported its first case of Guillain-Barré syndrome on Friday after a 64-year-old woman was diagnosed with the rare ...

“CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in ...